Age Old Dapsone in the Treatment of Idiopathic Thrombocytopenic Purpura—A Case Report With Review
Authors:
- Ria KunduRKRia Kundu
- Namrata SethiNSNamrata Sethi
- Abhimanyu GhoseAGAbhimanyu Ghose
- Rekha ChaudharyRCRekha Chaudhary
- 1 November 2013
- journal article
- case report
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 20 (6) , e723-e725
Abstract
Idiopathic thrombocytopenic purpura (ITP) is characterized by premature platelet destruction in the reticuloendothelial system due to the presence of autoantibodies against the platelet membrane proteins. Patients who are resistant to the traditional treatment options that include the administration of steroids, IV immunoglobulin, and antirhesus D immunoglobulin and the performance of a splenectomy are diagnosed to have refractory chronic ITP. Management options in these patients are not well defined. Long-term steroids, rituximab, danazol, azathioprine, and cyclophosphamide have variable efficacy and at the same time carry significant side effects. We present the case of a patient treated effectively with dapsone, a drug that is much safer than other drugs and which can be used before resorting to splenectomy; we also include a review of the literature establishing its role in the management of ITP.Keywords
This publication has 7 references indexed in Scilit:
- Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults – a report on 90 patientsEuropean Journal of Haematology, 2005
- Management of Adult Idiopathic Thrombocytopenic PurpuraAnnual Review of Medicine, 2005
- Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapyExpert Reviews in Molecular Medicine, 2004
- The Incidence of Idiopathic Thrombocytopenic Purpura in Adults Increases With AgeBlood, 1999
- Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]Blood, 1996
- Dapsone for refractory chronic idiopathic thrombocytopenic purpuraBritish Journal of Haematology, 1995
- Dapsone for autoimmune thrombocytopenic purpuraAmerican Journal of Hematology, 1993